Published by Josh White on 27th February 2019
(Sharecast News) - Pharmaceutical development company Nuformix has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to begin human pharmacokinetics studies for its lead asset, NXP001, it announced on Wednesday.
URL: http://www.digitallook.com/dl/news/story/28688463/...